DYNAVAX TECHNOLOGIES CORP 3 SEC Filings

Filed On	Filing
13 May 2025	Form 3: Metzinger Joseph Anthony, VP, Chief Accounting Officer No securities owned
05 Feb 2025	Form 3: Silvernail Lauren P, Director No securities owned
05 Feb 2025	Form 3: Emini Emilio, Director No securities owned
24 Oct 2024	Form 3: Deep Track Biotechnology Master Fund, Ltd., 10% owner and 2 others Holds 17,791,486 shares of Common Stock, par value $0.001 per share
05 Apr 2024	Form 3: Slebir John L, SVP General Counsel Holds 10,085 shares of Common Stock
14 Dec 2021	Form 3: Sun Elaine D, Director Holds 0 shares of Common Stock
21 Oct 2021	Form 3: Myers Scott Dunseth, Director Holds 0 shares of No securities owned.
02 Mar 2021	Form 3: MacDonald Kelly, SVP and CFO Holds 0 shares of Common Stock
24 Sep 2020	Form 3: Paradiso Peter R., Director Holds 3,000 shares of Common Stock
22 Jul 2020	Form 3: MacGregor Brent, Director Holds 0 shares of Common Stock
21 Jul 2020	Form 3: Eastland Julia Marie, Director Holds 0 shares of Common Stock
15 May 2020	Form 3: Burgess Justin, Principal Accounting Officer
22 Aug 2019	Form 3: Hack Andrew A. F., Director Holds 7,525,000 shares of Common Stock
31 May 2019	Form 3: Spencer Ryan, Co-President and Senior VP Holds 20,707 shares of Common Stock
09 Feb 2015	Form 3: Brege Laura, Director Holds 0 shares of Common Stock
06 Feb 2014	Form 3: Johnson David Louis, Vice President & CAO Holds 0 shares of Common Stock
11 Jul 2013	Form 3: Janssen Robert, Chief Medical Officer and VP Holds 25,481 shares of Common Stock
08 Jul 2013	Form 3: Ricciardi Natale S, Director Holds 0 shares of Common Stock
03 May 2013	Form 3: Gray Eddie, Director Holds 0 shares of Common stock
27 Mar 2013	Form 3: Novack David F, Senior Vice President Holds 4,500 shares of Common Stock

Comments